TMD LAB Collaborates With US NIST to Reveal the Secrets of Shape-memory Polymer Materials
Retrieved on:
Monday, November 14, 2022
Health, Medical Devices, Surgery, Health Technology, Research, Science, Biotechnology, Shape-memory polymer, Cooperative research and development agreement, LAB, Silicon, U.S. Department of Commerce Office of Security, NIST, National Institute of Standards and Technology, DNA, Commerce, SMP, Research, Thermoregulation, TMD, Development, Biofilm, U.S. Department of Defense Strategy for Operating in Cyberspace, Medical device, CRADA
TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022.
Key Points:
- TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022.
- TMD LAB and the biomaterials group of NIST signed a confidential disclosure agreement for joint research in April last year.
- In addition, basic research on the structural properties of SMP of TMD LAB has been conducted.
- TMD LAB Co., Ltd., established in 2018, is a company that is developing implantable medical devices using Shape Memory Polymer (SMP), high-tech new materials.